Business
Director/PDMR Shareholding
Venture Life Group PLC announced that Chief Executive Officer Jerry Randall sold 387,705 ordinary shares at a volume-weighted average price of 66.22 pence per share, totaling approximately £256,600. This sale was to cover the exercise price of options and resulting tax liabilities, following his exercise of options for 483,333 shares. After this transaction, Mr. Randall beneficially holds 2,348,828 ordinary shares, representing 1.82% of the company's issued share capital. Disclaimer*
About this update from Venture Life Group Plc
[{"type":"text","content":"\n\n9 January 2026\nVENTURE LIFE GROUP PLC\n \n(\"Venture Life\", \"VLG\" or the \"Company\")\n \nDirector/PDMR Shareholding\nFurther to the announcement on 2 January 2026 of the exercise of options over 483,333 ordinary shares of 0.3 pence each in the capital of the Company (\"Ordinary Shares\") by Jerry Randall (Chief Executive Officer), the Company has been notified that, in order to satisfy the payment of the exercise price of the options and the personal tax liabilities resulting from the exercise of the options, Jerry Randall has sold 387,705 Ordinary Shares at a volume-weighted average price of 66.22 pence per Ordinary Share (\"the \"Share Sale\").\nFollowing the Share Sale, Jerry Randall beneficially holds 2,348,828 Ordinary Shares representing approximately 1.82 per cent. of the Company's issued share capital.\n \nFor further information, please contact:\nVenture Life Group PLC +44 (0) 1344 578004\nJerry Randall, Chief Executive Officer\nDaniel Wells, Chief Financial Officer \nCavendish Capital Markets Limited (Nomad and Broker) +44 (0) 20 7720 0500 \nStephen Keys/George Lawson (Corporate Finance)\nMichael Johnson (Sales) \n \nAbout Venture Life (www.venture-life.com)\nVenture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, L...